Advertisement
Journal Home
Search for
Cover Image

Current Issue

January 2010 | Vol. 7, No. 1

Traumatic Brain Injury

Featured Articles
Cell Death Mechanisms and Modulation in Traumatic Brain Injury
Mitochondrial Damage: A Target for New Therapeutic Horizons
Involvement of Pro- and Anti-Inflammatory Cytokines and Chemokines in the Pathophysiology of Traumatic Brain Injury
Calpain as a Therapeutic Target in Traumatic Brain Injury
The Evidence for Hypothermia as a Neuroprotectant in Traumatic Brain Injury
Antioxidant Therapies for Traumatic Brain Injury
Statins in Traumatic Brain Injury
Substance P Antagonists as a Therapeutic Approach to Improving Outcome Following Traumatic Brain Injury
Traumatic Brain Injury and Aging: Is a Combination of Progesterone and Vitamin D Hormone a Simple Solution to a Complex Problem?
Use of Magnesium in Traumatic Brain Injury
Biomarkers for the Diagnosis, Prognosis, and Evaluation of Treatment Efficacy for Traumatic Brain Injury
Clinical Trials in Traumatic Brain Injury: Past Experience and Current Developments
IMPACT Recommendations for Improving the Design and Analysis of Clinical Trials in Moderate to Severe Traumatic Brain Injury
Huntington Study Group Abstracts

JOURNAL ACCESS

Full-text articles are available from January 2004 to the present. Access to abstracts is complimentary. Access to full text is limited to print subscribers. Nonsubscribers may purchase individual articles or Register or login to:

Activate Online Access

Buy a Subscription Now

FEATURES

Email Alert

ABOUT ASENT

The purpose of the American Society for Experimental NeuroTherapeutics is to:

• Provide a forum for the broadly defined interest areas of academia, government, industry, and advocacy concerned with the field of neurotherapeutics
• Promote dialogue, understanding, and cooperation among the interested groups
• Develop information and seek consensus on matters germane to the organization's mission
• Organize education and training for healthcare practitioners, biomedical scientists, and officials participating in the neurotherapeutics field.

ASENT



Neurotherapeutics is published by Elsevier for the American Society for Experimental NeuroTherapeutics.

Advertisement